Journal article · 2022 · Open access
1317MO Non-OS endpoints in oncology: Strategies to bridge the gap in value attribution by regulators, payors, oncologists, and patients
Annals of Oncology, 33, S1146 · Published 1 September 2022 · DOI 10.1016/j.annonc.2022.07.1450
In brief
“1317MO Non-OS endpoints in oncology: Strategies to bridge the gap in value attribution by regulators, payors, oncologists, and patients” is a 2022 journal article by A. Fameli and 6 co-authors, published in Annals of Oncology. OpenAlex counts 0 citations as of 22 November 2026. It is open access: the full text is free to read at Annals of Oncology.
- Citations
- 0
- Authors
- 7
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Fameli, A., Glover, M., Gutierrez, B., Cimen, A., Nelson, L. A., Altimari, S., & Paulsson, T. (2022). 1317MO Non-OS endpoints in oncology: Strategies to bridge the gap in value attribution by regulators, payors, oncologists, and patients. Annals of Oncology, 33, S1146. https://doi.org/10.1016/j.annonc.2022.07.1450
MLA 9
Fameli, A., et al. “1317MO Non-OS endpoints in oncology: Strategies to bridge the gap in value attribution by regulators, payors, oncologists, and patients.” Annals of Oncology, vol. 33, 2022, p. S1146. https://doi.org/10.1016/j.annonc.2022.07.1450.
Chicago
Fameli, A., M. Glover, Ben Gutierrez, A. Cimen, Linda A. Nelson, Shannon Altimari, and T. Paulsson. 2022. “1317MO Non-OS endpoints in oncology: Strategies to bridge the gap in value attribution by regulators, payors, oncologists, and patients.” Annals of Oncology 33: S1146. https://doi.org/10.1016/j.annonc.2022.07.1450.
Harvard
Fameli, A. et al. (2022) ‘1317MO Non-OS endpoints in oncology: Strategies to bridge the gap in value attribution by regulators, payors, oncologists, and patients’, Annals of Oncology, 33, p. S1146. doi:10.1016/j.annonc.2022.07.1450.
IEEE
A. Fameli et al., “1317MO Non-OS endpoints in oncology: Strategies to bridge the gap in value attribution by regulators, payors, oncologists, and patients,” Annals of Oncology, vol. 33, p. S1146, 2022, doi: 10.1016/j.annonc.2022.07.1450.
BibTeX
@article{fameli2022endpoints,
title = {{1317MO Non-OS endpoints in oncology: Strategies to bridge the gap in value attribution by regulators, payors, oncologists, and patients}},
author = {Fameli, A. and Glover, M. and Gutierrez, Ben and Cimen, A. and Nelson, Linda A. and Altimari, Shannon and Paulsson, T.},
journal = {Annals of Oncology},
year = {2022},
volume = {33},
pages = {S1146},
doi = {10.1016/j.annonc.2022.07.1450},
url = {https://doi.org/10.1016/j.annonc.2022.07.1450}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- overall survival
- value attribution
- regulatory approval
- oncologists' attitudes
- patient perspectives
- accelerated approval
- crossover
- loss to follow-up
Work with this paper
Most-cited papers in Mathematics
- Random ForestsLeo Breiman · Machine Learning · 2001 · 142,830 citations
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple TestingYoav Benjamini, Yosef Hochberg · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1995 · 113,923 citations
- Fitting Linear Mixed-Effects Models Using lme4Douglas M. Bates, Martin Maechler, Benjamin M. Bolker and 1 more · Journal of Statistical Software · 2015 · 100,328 citations
- The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations.Reuben M. Baron, David A. Kenny · Journal of Personality and Social Psychology · 1986 · 95,866 citations
- Using multivariate statisticsBarbara Gerson Tabachnick, Linda S. Fidell · 1983 · 79,867 citations
Questions about this paper
How do I cite this paper in APA style?
Fameli, A., Glover, M., Gutierrez, B., Cimen, A., Nelson, L. A., Altimari, S., & Paulsson, T. (2022). 1317MO Non-OS endpoints in oncology: Strategies to bridge the gap in value attribution by regulators, payors, oncologists, and patients. Annals of Oncology, 33, S1146. https://doi.org/10.1016/j.annonc.2022.07.1450
How many times has this paper been cited?
0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Annals of Oncology: sign in and open the full text from this page.
Who wrote this paper?
A. Fameli, M. Glover, Ben Gutierrez, A. Cimen, Linda A. Nelson, Shannon Altimari, T. Paulsson.
What is the DOI of this paper?
10.1016/j.annonc.2022.07.1450, permanently at https://doi.org/10.1016/j.annonc.2022.07.1450. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.